Compound Detail
CHEMBL406050
PX-12 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL406050 |
| Name | PX-12 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | BPBPYQWMFCTCNG-UHFFFAOYSA-N |
8
Targets
15
Activities
1
Assay Types
0
PK Parameters
20
Publications
1
Known Names
2
Indications
1
Mechanisms
Molecular Properties
188.3
MW (Da)
2.95
ALogP
3
HBA
1
HBD
28.7
PSA (Ų)
0.74
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Thioredoxin inhibitor | INHIBITOR | Thioredoxin | ✓ | ✓ |
Indications
Pancreatic Neoplasms Neoplasms
Activity Summary
IC50 15 meas. best 6.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Replicase polyprotein 1ab CHEMBL4523582 | IC50 | 6.85 | 5.41 | 140.0 | 7 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 6.17 | 6.17 | 670.0 | 1 |
| Thioredoxin CHEMBL2010624 | IC50 | 5.68 | 5.68 | 2110.0 | 1 |
| Replicase polyprotein 1ab CHEMBL4295557 | IC50 | 5.12 | 5.12 | 7600.0 | 1 |
| HeLa CHEMBL399 | IC50 | 5.05 | 5.05 | 9000.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 4.92 | 4.92 | 12000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.91 | 4.79 | 12300.0 | 2 |
| Thioredoxin reductase 1, cytoplasmic CHEMBL1927 | IC50 | 4.81 | 4.81 | 15400.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18617414 | 10.1016/j.bmc.2008.06.028 | MCF7 | 4 |
| 18502639 | 10.1016/j.bmcl.2008.05.028 | MCF7 | 4 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 3 |
| 23327656 | 10.1021/jm301775s | Thioredoxin | 3 |
| 22128876 | 10.1021/jm201359d | Raji | 3 |
| 18617414 | 10.1016/j.bmc.2008.06.028 | M21 | 2 |
| 22128876 | 10.1021/jm201359d | Mus musculus | 2 |
| 33191083 | 10.1016/j.bmc.2020.115860 | Replicase polyprotein 1ab | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 22128876 | 10.1021/jm201359d | NON-PROTEIN TARGET | 2 |
| 22128876 | 10.1021/jm201359d | T-24 | 1 |
| 22128876 | 10.1021/jm201359d | EMT6 | 1 |
| 37244162 | 10.1016/j.ejmech.2023.115491 | SARS-CoV-2 | 1 |
| 22128876 | 10.1021/jm201359d | K562 | 1 |
| 22128876 | 10.1021/jm201359d | MEF | 1 |
| 22128876 | 10.1021/jm201359d | PBMC | 1 |
| 18617414 | 10.1016/j.bmc.2008.06.028 | HT-29 | 1 |
| 18502639 | 10.1016/j.bmcl.2008.05.028 | M21 | 1 |
Data from ChEMBL 36 via Core Engine